Login

Glynn Wilson, CEO, TapImmune Inc 00:00:00

Share On Facebook Share On Twitter

Tapimmune CEO Glynn Wilson talk about the company.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Eric Pharis Discusses BlackBoxStocks' Tools for Profiting in the Market | Eric Pharis, Founder, BlackBoxStocks Inc.
00:10:00
During a post-NRF 2022 panel, VTEX Co-CEO Mariano Gomide de Faria discusses entrepreneurship with David Schonthal.|Gomide de Faria is our Founder and Co-Chief Executive Officer,
00:10:00
Disruptive Innovation in Investment Management: Unveiling the Jobs to be Done|David Taten,Partner,Teten Advisors, LLC
00:10:00
Nordic Real Estate Acquisition Discussed by CEO | Erik Selin, CEO, Fastighets AB Balder.
00:10:00
Economic Review and Upcoming Data with Rob McDougle | Rob McDougle, Vice-President, Zhang Financial.
00:10:00
Private Market Valuations and Capital Flows at PE Firms | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
Get Financial Peace of Mind with a Quick Call to Deerfield Financial Advisors
00:10:00
Looked ahead at the future of generative AI|Danel Dayan,Venture Capital Investor,Battery Ventures
00:10:00
Assessing Market Trends, Margin Pressures, and ESG Investments | Prince Maximillian of Liechtenstein , CEO , LGT Group.
00:10:00
Apacer Technology's 20th anniversary, thank you for your company and participation, let us write another exciting one together|CSO, Apacer Technology Inc
00:10:00
Understanding Risk Management at Alaska Investimentos | Marcos Yamamoto serves - Director of Risk Management at Alaska Investimentos.
00:10:00
Resolute Mining: CEO Terry Hulahan on Overcoming Challenges and Gold Production Growth in West Africa|Terry Holohan,Managing Director and Chief Executive Officer,Resolute Mining Ltd.

© 2026 Nehu